Modelling the lifetime cost-effectiveness of catheter ablation for atrial fibrillation with heart failure.
Lan GaoMarj MoodiePublished in: BMJ open (2019)
Offering catheter ablation procedure to patients with systematic paroxysmal or persistent AF who failed to respond to antiarrhythmic drugs was associated with higher costs, greater benefits. When compared with medical therapy alone, this intervention is not cost-effective from an Australia healthcare system perspective.
Keyphrases
- catheter ablation
- atrial fibrillation
- heart failure
- left atrial
- left atrial appendage
- oral anticoagulants
- direct oral anticoagulants
- randomized controlled trial
- healthcare
- percutaneous coronary intervention
- minimally invasive
- left ventricular
- acute coronary syndrome
- bone marrow
- acute heart failure
- cardiac resynchronization therapy